Security key
74319B502
Profound Medical Corp. - Common Shares (PROF)
CUSIP: 74319B502
Q2 2026 13F Holders as of 30 Jun 2026
- Security type / class
- Equity / Common Shares
- Total 13F shares
- 5,419,834
- Total 13F value
- $36,057,023
- Share change
- +152,594
- SEC-reported price per share
- $6.65
- Number of holders
- 19
- Value change
- +$1,014,269
- Number of buys
- 5
- Number of sells
- 6
- Shares outstanding
- 29,881,634
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2026
Institutions
19
Top holders
10
PROF full security history
Ownership snapshot
Full 13F holder table
Previous quarter: Q4 2025
Profound Medical Corp. SEC filings
Profound Medical Corp. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 74319B502
Recent filing periods:
Ownership snapshot
Top reported holders of PROF - Profound Medical Corp. - Common Shares (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
GAGNON SECURITIES LLC
Disclosed value leader
GAGNON SECURITIES LLC
Comparable rows
15/15
Latest evidence
31 Mar 2026
13D/G
13F
3/4/5
Lead comparable stake: 11%
13D/G row: GAGNON SECURITIES LLC
Showing 1-6 of 15 holder rows.
Quick read
GAGNON SECURITIES LLC leads the comparable SEC ownership view at 11%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens GAGNON SECURITIES LLC's linked filing trail.
Comparable ownership
Top 5
GAGNON SECURITIES LLC
11%
LETKO, BROSSEAU & ASSOCIATES INC
4.9%
Arun S. Menawat
2%
FIL Ltd
7.8%
ROYCE & ASSOCIATES LP
3.7%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| GAGNON SECURITIES LLC |
13D/G
13F
Neil Gagnon · Company
|
11%
|
$15,796,627
3,346,743 shares
|
$0 | 31 Dec 2024 |
| LETKO, BROSSEAU & ASSOCIATES INC |
13F
13D/G
Company
|
4.9%
from 13D/G
|
$6,085,437
953,175 shares
|
— | 31 Mar 2026 |
| Arun S. Menawat |
3/4/5
CEO, Director
|
2%
|
$2,776,930
587,089 shares
|
— | 15 May 2025 |
| FIL Ltd |
13F
Company
|
7.8%
|
$15,163,203
2,340,000 shares
|
— | 31 Mar 2026 |
| ROYCE & ASSOCIATES LP |
13F
Company
|
3.7%
|
$7,142,188
1,116,348 shares
|
— | 31 Mar 2026 |
| Timelo Investment Management Inc. |
13F
Company
|
3.7%
|
$7,224,986
1,114,967 shares
|
— | 31 Mar 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
19
Shares
5,419,834
Rows available
19
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2026 vs Q4 2025 Across Filers
Q4 2025 holders
63
Q2 2026 holders
19
Holder diff
-44
| Investor | Q4 2025 Shares | Q2 2026 Shares | Share Diff | Share Chg % | Q4 2025 value | Q2 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend